Fenbendazole & Ivermectin: What Science Says About Their Potential Against Cancer

Fenbendazole and ivermectin, two common antiparasitic medications, are gaining attention for their potential role in cancer treatment. Researchers and patients are exploring whether these low-cost drugs can slow tumor growth, enhance conventional therapies, and improve survival rates. A new book delves into their effects on cancer cells, the clinical evidence supporting their use, and real-world dosing strategies. It also discusses potential synergies with traditional treatments and the challenges of gaining medical acceptance for repurposed drugs. By separating fact from speculation, the book aims to inform patients and caregivers about these emerging possibilities in cancer therapy.